Ginsenoside alleviates sepsis related acute lung injury by inhibiting the destruction of alveolar epithelial barrier mediated by EVs secreted by alveolar macrophages
International Immunopharmacology · 2026-11 · 189 · 117394
DOI: 10.1016/j.intimp.2026.117394 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Hao Ming und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Ginsenosides, Acute Lung Injury, Sepsis, Macrophages, Alveolar. Die Arbeit nennt 36 Literaturangaben. Gefördert von: China International Medical Foundation, Fundamental Research Funds for the Central Universities, Wuhan University.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-associated acute lung injury (SALI) is a critical complication of sepsis, characterized by alveolar epithelial barrier disruption and excessive inflammation, which contributes substantially to morbidity and mortality. The present study investigates the protective effects of ginsenoside Rb1 on SALI and elucidates its underlying mechanisms involving alveolar macrophage-derived extracellular vesicles (EVs). Using a cecal ligation and puncture (CLP) murine model, LPS-stimulated alveolar macrophages, and EV isolation and characterization, we evaluated Rb1's influence on survival, lung histopathology, inflammatory cytokine levels, alveolar epithelial barrier proteins (ZO-1, Occludin, E-cadherin), and NF-κB signaling. Rb1 pretreatment significantly improved survival, reduced pulmonary edema and tissue injury, and decreased inflammatory cytokines in bronchoalveolar lavage fluid. Mechanistically, Rb1 suppressed the secretion of macrophage-derived EVs that mediate alveolar epithelial injury and restored barrier-associated protein expression both in vitro and in vivo. Bioinformatic analyses identified NF-κB signaling as a key pathway influenced by Rb1-modulated EVs, and experimental validation confirmed that Rb1 attenuated NF-κB activation in alveolar epithelial cells. Collectively, these findings demonstrate that Rb1 alleviates SALI by modulating macrophage-EV-mediated epithelial barrier disruption and inhibiting NF-κB-driven inflammation. This study highlights a novel intercellular mechanism underlying Rb1's protective effects and provides a mechanistic rationale for targeting EV-mediated communication as a therapeutic strategy in sepsis-induced lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Intensive Care Unit, Tianyou Hospital of Wuhan University of Science & Technology, Wuhan, China.
- Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: ling.gao@whu.edu.cn.
Förderung
- China International Medical Foundation
- Fundamental Research Funds for the Central Universities
- Wuhan University
- National Natural Science Foundation of China
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Ming, H., Zhang, Y. Y., Chen, L., Yu, Y. L., Liu, S. P., Zhan, L. Y., & Gao, L. (2026). Ginsenoside alleviates sepsis related acute lung injury by inhibiting the destruction of alveolar epithelial barrier mediated by EVs secreted by alveolar macrophages. International Immunopharmacology, 189, 117394. https://doi.org/10.1016/j.intimp.2026.117394
Vancouver
Ming H, Zhang YY, Chen L, Yu YL, Liu SP, Zhan LY, et al. Ginsenoside alleviates sepsis related acute lung injury by inhibiting the destruction of alveolar epithelial barrier mediated by EVs secreted by alveolar macrophages. International Immunopharmacology. 2026;189:117394. doi:10.1016/j.intimp.2026.117394
BibTeX
@article{Ming2026,
author = {Ming, Hao and Zhang, Yun-Yan and Chen, Liu and Yu, Yan-Li and Liu, Shi-Ping and Zhan, Li-Ying and Gao, Ling},
title = {Ginsenoside alleviates sepsis related acute lung injury by inhibiting the destruction of alveolar epithelial barrier mediated by EVs secreted by alveolar macrophages},
journal = {International Immunopharmacology},
year = {2026},
volume = {189},
pages = {117394},
doi = {10.1016/j.intimp.2026.117394}
}
EUVIMED